BeStock  
Stocks › Biotechnology › ORKA

Oruka Therapeutics ORKA

US equityMarket cap rank #1788Biotechnology
$95.81 −$1.76 (-1.80%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $95.81 0.00%
Open$95.86
Prev close$97.57
Day range$93.30 – $97.24
Volume1.98M
Market cap$6.50B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership115.0%-7.74 pts vs. prior quarter
Institutions holding312+3 vs. prior quarter
Insider trades (recent)7 buys / 43 sellsNet selling
Short interest9.76% of floatDays to cover 7.1 · as of 30 Oct 2026
Short-sale volume share15.3%5-day average of daily volume

Short-sale volume as % of daily volume

10%19%28%37%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$32.96M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$27.9MSuper−$5.0MBig−$7.7MMid−$10.9MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 39.3% of shares outstanding.

Largest holders

  • FMR14.96%
  • BlackRock7.68%
  • VR Management, LLC6.12%
  • Fairmount Funds Management LLC5.46%
  • Capital Research5.06%
  • RTW Investments, LP4.63%
  • State Street Global Advisors4.25%
  • Vanguard Capital Management, LLC3.90%

By investor type

  • Mutual Fund71.11%
  • Hedge Fund25.97%
  • VC/PE Fund13.55%
  • Individual/Insider2.16%
  • Private Company1.78%
  • Public Company1.64%
  • Sovereign Wealth Fund0.38%
  • Government Pension Fund0.26%

Reported short interest has fallen from 12.54% to 9.76% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +1,091,222 15.0%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +1,010,018 2.3%
Franklin Resources Mutual Fund 2026/Q3 +412,218 3.1%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +283,309 3.9%
Capital Research Mutual Fund 2026/Q3 +3,401,639 5.1%
FMR Mutual Fund 2026/Q3 +1,626,242 13.7%
RA Capital Management, L.P. VC/PE Fund 2026/Q3 +1,554,597 2.3%
BlackRock Mutual Fund 2026/Q3 +1,463,094 7.5%
Janus Henderson Group plc Mutual Fund 2026/Q3 +1,363,744 2.0%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,214,897 2.9%
Bellevue Asset Management AG Mutual Fund 2026/Q3 +1,150,182 2.4%
RTW Investments, LP Hedge Fund 2026/Q3 +1,080,882 4.6%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +1,068,087 1.6%
State Street Global Advisors Mutual Fund 2026/Q3 +1,059,629 4.0%
Summit Partners Public Asset Management, LLC Hedge Fund 2026/Q3 +658,301 1.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
11 Nov 2026 Kristine Ball Independent Director Derivative Exercise and Sale -18,000 $106.99 –
11 Nov 2026 Arjun Agarwal Senior VP of Finance & Treasurer Derivative Exercise and Sale -10,000 $107.00 14,219
1 Nov 2026 Lawrence Klein Chief Executive Officer Derivative Exercise and Sale -25,000 $98.40 923,128
19 Oct 2026 Paul Quinlan General Counsel Derivative Exercise and Sale -9,000 $79.49 29,995
14 Oct 2026 Joana Goncalves Chief Medical Officer Derivative Exercise and Sale -7,000 $77.71 31,771
11 Oct 2026 Arjun Agarwal Senior VP of Finance & Treasurer Derivative Exercise and Sale -9,999 $82.84 14,219
30 Sep 2026 Lawrence Klein Chief Executive Officer Derivative Exercise and Sale -25,000 $84.78 923,128
20 Sep 2026 Paul Quinlan General Counsel Derivative Exercise and Sale -10,000 $95.31 29,995
20 Sep 2026 Arjun Agarwal Senior VP of Finance & Treasurer Automatic Disposition -533 $95.75 14,219
14 Sep 2026 Paul Quinlan General Counsel Open Market Disposition -1,039 $95.71 29,995
14 Sep 2026 Joana Goncalves Chief Medical Officer Open Market Disposition -947 $95.71 31,771
14 Sep 2026 Joana Goncalves Chief Medical Officer Derivative Exercise and Sale -7,000 $94.22 31,771
14 Sep 2026 Lawrence Klein Chief Executive Officer Open Market Disposition -2,452 $95.71 923,128
14 Sep 2026 Arjun Agarwal Senior VP of Finance & Treasurer Open Market Disposition -560 $95.71 14,752
14 Sep 2026 Laura Sandler Chief Operating Officer Open Market Disposition -906 $95.71 235,478
10 Sep 2026 Arjun Agarwal Senior VP of Finance & Treasurer Derivative Exercise and Sale -9,459 $94.02 14,752
31 Aug 2026 Lawrence Klein Chief Executive Officer Derivative Exercise and Sale -75,000 $92.44 925,580
31 Aug 2026 Laura Sandler Chief Operating Officer Derivative Exercise and Sale -5,000 $92.01 236,384
23 Aug 2026 Larry Edwards Chief Commercial Officer Other Acquisition +100,000 – 100,000
23 Aug 2026 Larry Edwards Chief Commercial Officer Other Derivative Acquisition +20,000 $102.42 20,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 6,464,212 9.8% 7.1
15 Oct 2026 6,112,214 9.2% 7.3
30 Sep 2026 7,778,131 11.7% 6.3
15 Sep 2026 7,623,327 11.5% 11.6
31 Aug 2026 7,793,678 11.8% 9.3
14 Aug 2026 8,303,245 12.5% 11.3

Discussion

No comments yet — be the first to weigh in on ORKA.

Sign in to join the discussion.

Scroll to Top